Pfizer Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7170811035
USD
27.16
0.35 (1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Eli Lilly & Co.
Vertex Pharmaceuticals, Inc.
Bristol Myers Squibb Co.
Regeneron Pharmaceuticals, Inc.
Zoetis, Inc.
Johnson & Johnson
Merck & Co., Inc.
Pfizer Inc.
AbbVie, Inc.
Seagen Inc.
Horizon Therapeutics Plc

Why is Pfizer Inc. ?

1
High Management Efficiency with a high ROCE of 16.86%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.16 times
3
The company has declared Positive results for the last 3 consecutive quarters
  • NET PROFIT(9M) At USD 11,738.38 MM has Grown at 53.8%
  • DIVIDEND PER SHARE(HY) Highest at USD 5.44
  • RAW MATERIAL COST(Y) Fallen by -3.65% (YoY)
4
With ROCE of 12.73%, it has a very attractive valuation with a 1.99 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 2.26%, its profits have risen by 120.4% ; the PEG ratio of the company is 0.1
  • At the current price, the company has a high dividend yield of 428.1
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 2.26% in the last 1 year, much lower than market (S&P 500) returns of 14.11%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Pfizer Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pfizer Inc. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Pfizer Inc.
1.95%
-0.30
26.68%
S&P 500
20.78%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.60%
EBIT Growth (5y)
7.73%
EBIT to Interest (avg)
12.68
Debt to EBITDA (avg)
2.16
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
6,258.25
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
126.47%
Pledged Shares
0
Institutional Holding
68.35%
ROCE (avg)
16.86%
ROE (avg)
21.23%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.67
EV to EBIT
15.12
EV to EBITDA
11.12
EV to Capital Employed
2.08
EV to Sales
4.47
PEG Ratio
0.07
Dividend Yield
407.26%
ROCE (Latest)
13.77%
ROE (Latest)
18.34%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-11What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD 6,356 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

INTEREST COVERAGE RATIO(Q)

Lowest at 518.71

CASH AND EQV(HY)

Lowest at USD 14,984 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

OPERATING PROFIT(Q)

Lowest at USD 3,688 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 21.01 %

EPS(Q)

Lowest at USD -0.29

Here's what is not working for Pfizer Inc.

Interest Coverage Ratio
Lowest at 518.71
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Inventory Turnover Ratio
Lowest at 0 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Cash Flow
Lowest at USD 6,356 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD 3,688 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at 21.01 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

EPS
Lowest at USD -0.29
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv
Lowest at USD 14,984 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio